Anika Therapeutics, Inc. - ANIK

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 18
Latest filed: Mar 26, 2026
Form Count
4 9
SCHEDULE 13G/A 3
8-K 3
SCHEDULE 13D/A 2
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Mar 26, 2026 SCHEDULE 13G/A 0000102909-26-000682 View
Mar 23, 2026 4 Mar 19, 2026 0001193125-26-120005 View
Mar 17, 2026 4 Mar 14, 2026 0001193125-26-111492 View
Mar 17, 2026 4 Mar 14, 2026 0001193125-26-111494 View
Mar 17, 2026 4 Mar 14, 2026 0001193125-26-111502 View
Mar 17, 2026 4 Mar 14, 2026 0001193125-26-111511 View
Mar 11, 2026 4 Mar 09, 2026 0001193125-26-102238 View
Mar 11, 2026 4 Mar 09, 2026 0001193125-26-102239 View
Mar 11, 2026 4 Mar 09, 2026 0001193125-26-102240 View
Feb 26, 2026 8-K Feb 26, 2026 0001193125-26-073401 View
Feb 03, 2026 4 Feb 01, 2026 0001193125-26-036129 View
Jan 27, 2026 SCHEDULE 13D/A 0000902664-26-000511 View
Jan 08, 2026 SCHEDULE 13G/A 0001104659-26-002059 View
Jan 08, 2026 8-K Jan 07, 2026 0001193125-26-007655 View
Nov 21, 2025 SCHEDULE 13D/A 0000902664-25-005133 View
Nov 07, 2025 SCHEDULE 13G/A 0001104659-25-108057 View
Nov 05, 2025 8-K Nov 05, 2025 0001171843-25-007003 View
Oct 17, 2025 SCHEDULE 13G 0002052113-25-003599 View